Fibrin Sealants Market Updates

Global Fibrin Sealants Market size was valued at USD 592.9 Million in 2023 poised to grow from USD 639.1 Million in 2024 to USD 1165.6 Million by 2032, growing at a CAGR of 7.8% in the forecast period (2025-2032).

The global fibrin sealants market outlook is very competitive, with numerous global players competing for market share. The players are Johnson & Johnson, Baxter International, and CSL Behring. The players aim to broaden their product lines, invest in research and development, and develop strategic alliances. For instance, CSL Behring's strategy is to drive product innovation and execute global market penetration, while Johnson & Johnson's strategy is to advance its medical device portfolio and global distribution networks. 'Johnson & Johnson (USA)', 'Baxter International (USA)', 'CSL Behring (Australia)', 'Pfizer (USA)', 'Lantheus Medical Imaging (USA)', 'Fresenius Kabi (Germany)', 'Medtronic (Ireland)', 'Grifols (Spain)', 'AbbVie (USA)', 'CryoLife (USA)', 'Haemostatix (UK)', 'Tissuetech (USA)', 'Octapharma (Switzerland)', 'Laboratoires Théa (France)', 'B. Braun (Germany)'

The growing number of surgical procedures worldwide is a significant driver for the global fibrin sealants market growth. With an upsurge in the incidence of chronic ailments including cardiovascular diseases, cancer, and orthopedic disorders, the requirement for efficient hemostatic tools such as fibrin sealants in surgical procedures augments, driving market growth.

Growing Demand for Minimally Invasive Surgeries: The growing trend towards minimally invasive procedures is driving the demand for fibrin sealants. The sealants have the ability to offer quicker recovery, less bleeding, and better surgical results. Their use is being widely seen in applications such as cardiovascular and orthopedic procedures, where accuracy and rapid patient recovery are essential.

Why does a High Volume of Surgeries in North America Boost Fibrin Sealant Demand?